First of all, many transcriptomic/proteomic analyses in patients with ALS–FTSD or TDP-43 proteinopathy animal models do not report parkin expression alterations [102,103,104,105,106]. This evidence concerns the gene PRKN and amyotrophic lateral sclerosis.